Lv6
2272 积分 2023-09-06 加入
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial
4天前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
13天前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
17天前
已完结
Response Evaluation Criteria in Cancer of the liver version 6 (Response Evaluation Criteria in Cancer of the Liver 2021 revised version)
17天前
已完结
Comparison of mechanical and thermal effects of focused ultrasound on drug delivery efficiency and toxicity for pancreatic cancer treatment
1个月前
已关闭
Combination of chemotherapy and focused ultrasound for the treatment of unresectable pancreatic cancer: a proof-of-concept study
1个月前
已完结
Bayesian clinical trials in action
1个月前
已完结
A Calcium Alginate Hydrogel Microsphere‐Based Transcatheter Arterial Viroembolization Strategy for Hepatocellular Carcinoma
1个月前
已完结
[Lipiodol with and without Gelfoam in primary liver tumors. Plasma levels of Mitoxantrone and clinical results]
1个月前
已关闭
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
1个月前
已完结
皖公网安备34019202002308
